Moreover, 33% of all tested melanoma and lung adenocarcinoma cell lines have inactivating mutations in at least one IFN-у pathway component [60], suggesting that inactivation of the IFN-у pathway can lead to evasion of cytokine induced cell cycle arrest and cytokine mediated tumor surveillance. The gene discussed is IFNA1; the disease is lung adenocarcinoma.